亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Organ Homing Genes of Cancer Metastases

技術優勢
Can identify the localization site of metastasisPotential for improving the prognosis of these metastatic-associated cancers.Detect the early onset of cancer and preempt the progression of metastasis,Simple method for screening cancer- Body fluids and/or tissue samples could be used.Unlike current treatment options, the technology offers a reliable method to cure metastatic cancer.Novel and specific targetsOffers therapeutic antibodies against novel and specific targets (i.e. organ-homing peptides specific to a cancer) to eradicate metastasis.Cells with the potential to metastasize could be identified concurrently with diagnosis of primary tumor.
詳細技術說明
The invention describes novel biological molecules for the prognosis, diagnosis and treatment of cancer. Specifically, the technology identifies novel organ-homing proteins used by cancer cells for their seeding into organs of metastasis. Primary tumors tend to metastasize to specific distant “target” organs. For example, prostate cancer often metastasize to the bone, breast cancer metastasize to the liver etc. The physiologic basis of such targeting remains unknown but it is well known that once the cancer has metastasized an individual’s chances of survival typically decreases. Thus, there is a great need to develop biomarkers that can detect subclinical metastasis or detect the risk of metastasis, treat such cancers and/or monitor disease progression or treatment. The present invention identifies a set of liver targeting domains that could be used as prognostic and diagnostic markers. Further, the invention describes antibodies against such liver targeting domains for therapeutic intervention.
*Abstract
None
*Publications
Manuscript under preparation.
*Stage of Development
Georgetown researchers have identified 3 specific homing genes for colon cancer that metastasizes to the liver using tissue samples from individuals with: 1) colon cancer metastasis to the liver; 2) primary colon cancers that had metastasized at the time of diagnosis; 3) invasive colon cancers without known metastasis; and all were compared with samples from normal colon tissues and samples from individuals with breast cancer due to the relatively low propensity of breast cancer for initial metastasis to the liver.Also, several other cancers, including breast and prostate, have also been examined. Currently, the identified organ-homing biomolecules specific for such cancers are being characterized.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備